fetching data ...
version:
1.02
Home
Search:
Free Text Search
List:
Abstract Titles
Sessions
Authors
Keywords
Bookmarks
Include in search:
all years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
List: Authors
Go!
Years:
2026 (London, England)
Total Number of items found:
15678
in
1568
pages.
Goto page:
10
50
100
Jump to page containing Authors starting with :
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Authors
[1]
Þorarinsdottir, K.
2026
2026 AB0181
CAN ANTI-INTERFERON AUTOANTIBODY PROFILES DEFINE CLINICAL TRAJECTORIES AND CANCER RISK IN SARCOIDOSIS?
,
B. Árnadóttir, K. Þorarinsdottir, S. Ó. Haraldsdóttir, B. Gudbjornsson
[1]
’auria, F. D
2026
2026 AB0604
CLINICAL PHENOTYPES IN IgG4-RD: ACR/EULAR CLASSIFICATION AND PRACTICAL LIMITATIONS
,
M. Caliste, F. D ’auria, L. Mastromanno, F. Carfora, C. Giordano, C. Alessandri, M. Visentini, F. Conti, R. Priori
[1]
Aabakken, L.
2026
2026 POS0013
HIGH-DEFINITION SPATIAL TRANSCRIPTOMICS REVEALS ALTERED T CELL STATES AND EPITHELIAL STRESS RESPONSES IN THE SMALL INTESTINE OF SYSTEMIC SCLEROSIS PATIENTS
,
L. Much, E. Pachera, H. Fretheim, K. E. Lundin, A. Hofman, Ø. Midtvedt, E. Bækkevold, L. Aabakken, L. Li, P. Stauffer, M. Asadikorayem, S. Xu, B. Burja, M. Scharl, C. Mihai, Ø. Molberg, O. Distler, A. M. Hoffmann-Vold
[1]
Aabel, M. M.
2026
2026 OP0264
MULTI-TISSUE TRANSCRIPTOMICS ANALYSIS OF EARLY CTD-ILD REVEALS CONSISTENT MOLECULAR SIGNATURES POINTING TO INTERFERON RESPONSE MECHANISMS
,
P. Stauffer, V. Palchevskiy, L. Much, P. P. Diep, M. M. Aabel, N. Moe, T. Gaisl, C. Steinack, S. Lari, E. Pachera, Ø. Molberg, O. Distler, S. S. Weigt, J. Belperio, A. M. Hoffmann-Vold
[1]
Aadahl, M.
2026
2026 POS0344-HPR
ISOLATION AND LONELINESS IN RHEUMATOLOGY: A SCOPING REVIEW OF FACTORS INFLUENCING ACCESS, UPTAKE, RETENTION, AND EFFECTS OF SOCIAL PRESCRIBING
,
S. M. Abild, S. Schuster, J. Midtgaard, M. Aadahl, B. Glintborg, B. A. Esbensen
[1]
Aaen, K. T.
2026
2026 AB1275
THE ONE-MINUTE SIT-TO-STAND TEST IS AN ALTERNATIVE TO THE SIX-MINUTE WALK TEST IN SYSTEMIC SCLEROSIS
,
E. Naeser, A. Lynggaard Riis, K. T. Aaen, K. Søndergaard, E. Bendstrup
[2]
Aaløkken, T. M.
2026
2026 POS0278
PHENOTYPIC CLUSTERING IN SJÖGREN’S DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTRE EUROPEAN REAL-WORLD STUDY
,
K. Kastrati, F. Weber, M. Sprecher, E. Langballe, D. Molnar, L. T. Göthans, K. Anderle, H. Fretheim, H. Jenssen Bjørkekjær, P. P. Diep, M. Mæhlen, D. Mrak, N. Rempp, B. Müller, C. Brunborg, C. Bruni, C. Clarenbach, T. Frauenfelder, T. M. Aaløkken, N. Moe, H. Prosch, Ø. Midtvedt, H. Andersson, P. Studenic, Ø. Molberg, D. Aletaha, O. Distler, H. Lechner-Radner, A. M. Hoffmann-Vold
2026 POS1020
CHANGING TREATMENT PATTERNS AND THE IMPACT ON PULMONARY OUTCOMES IN SJÖGREN’S DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTRE EUROPEAN REAL-WORLD STUDY
,
K. Kastrati, M. Sprecher, F. Weber, E. Langballe, D. Molnar, L. T. Göthans, K. Anderle, H. Fretheim, H. Jenssen Bjørkekjær, P. P. Diep, M. Mæhlen, D. Mrak, N. Rempp, B. Müller, C. Brunborg, C. Bruni, C. Clarenbach, T. Frauenfelder, T. M. Aaløkken, N. Moe, H. Prosch, Ø. Midtvedt, H. Andersson, P. Studenic, Ø. Molberg, D. Aletaha, O. Distler, H. Lechner-Radner, A. M. Hoffmann-Vold
[11]
Aarrestad Provan, S.
2026
2026 OP0190
LONG-TERM OUTCOMES OF JUVENILE IDIOPATHIC ARTHRITIS IN ADULTHOOD: A POPULATION-BASED MATCHED COMPARATOR STUDY FROM NORWAY.
,
I. Bardan, L. M. Sundbakk, J. Sexton, T. K. Kvien, Ø. Molberg, E. Kristianslund, S. Aarrestad Provan, A. B. Aga
2026 OP086
SUBTYPE-SPECIFIC CANCER RISK WITH JAK INHIBITORS AND BIOLOGIC DMARDS IN RHEUMATOID ARTHRITIS: COMPARATIVE ANALYSIS WITHIN THE JAK-POT COLLABORATION
,
B. Ciribè, B. Meuleman, R. Aymon, D. Mongin, B. Gilbert, R. Guemara, D. Choquette, C. Codreanu, L. Coupal, I. Flouri, R. Fritsch-Stork, R. F. Caporali, D. Huschek, F. Iannone, T. K. Kvien, L. Otero Varela, D. Nordström, K. Pavelka, M. Pombo-Suarez, S. Aarrestad Provan, Z. Rotar, P. Sidiropoulos, E. Vieira-Sousa, A. Strangfeld, J. Závada, N. Trokovic, N. Inanc, G. Kenar Artin, D. S. Courvoisier, A. Finckh, K. Lauper
2026 POS0029
INCIDENCE OF INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK INHIBITORS (INCLUDING SUBTYPES), TNF INHIBITORS AND OTHER bDMARDs: RESULTS FROM THE JAK-POT COLLABORATION
,
O. Zimmermann, R. Aymon, D. Mongin, B. Gilbert, R. Guemara, D. Choquette, L. Coupal, C. Codreanu, A. Strangfeld, D. Huschek, K. Hyrich, S. S. Zhao, F. Iannone, R. F. Caporali, T. K. Kvien, S. Aarrestad Provan, R. Fritsch-Stork, D. Nordström, N. Trokovic, K. Pavelka, J. Závada, M. Pombo-Suarez, L. Otero Varela, E. Vieira-Sousa, Z. Rotar, P. Sidiropoulos, A. Repa, N. Inanc, G. Kenar Artin, D. S. Courvoisier, K. Lauper, A. Finckh
2026 POS0036
COST-EFFECTIVENESS OF HERPES ZOSTER VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
,
G. Hagen, A. K. Opheim, J. Ovrebo, E. Aas, S. Aarrestad Provan
2026 POS0192
COST-EFFECTIVENESS OF A HIGH-INTENSITY EXERCISE PROGRAM FOR AXIAL SPONDYLOARTHRITIS: A MODELLING STUDY
,
F. Pavia, S. Aarrestad Provan, E. Aas, H. Solveig Dagfinrud, S. Sveaas, I. J. Berg, L. M. Sundbakk, G. Hagen
2026 POS0422
COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN IN 50-YEAR-OLD PATIENTS WITH RHEUMATOID ARTHRITIS IN NORWAY-A MARKOV MODELLING ANALYSIS
,
M. Alvino, S. Aarrestad Provan, E. Aas, G. Hagen
2026 POS1233
CURRENT SYMPTOM-BASED DETECTION OF RA-ILD RESULTS IN UNDER-DETECTION, ADVANCED DISEASE AND EXCESS MORTALITY: A MULTICENTER NORWEGIAN QUALITY ASSURANCE AUDIT
,
E. Ikdahl, B. Døskeland, L. T. Bertelsen, G. Bakland, T. T. Pedersen, H. Yi, P. P. Diep, L. M. Sundbakk, S. Aarrestad Provan, A. M. Hoffmann-Vold
2026 POS1279
MACHINE LEARNING TO PREDICT REMISSION BETWEEN SIX AND 24 MONTHS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM THE JAK-pot COLLABORATION
,
Z. Salis, D. Mongin, R. Aymon, D. Choquette, L. Coupal, C. Codreanu, F. Iannone, R. F. Caporali, T. K. Kvien, S. Aarrestad Provan, R. Fritsch-Stork, D. Nordström, N. Trokovic, K. Pavelka, J. Závada, A. M. Rodrigues, Z. Rotar, P. Sidiropoulos, I. Flouri, C. Lamacchia, M. Iudici, D. S. Courvoisier, K. Lauper, A. Finckh
2026 POS1312
SELECTING THE RIGHT SCORE: HOW DISEASE ACTIVITY COMPOSITE SCORES INFLUENCE TREATMENT OUTCOMES WITH IL-6-INHIBITORS, JAK-INHIBITORS AND TNF-INHIBITORS IN RHEUMATOID ARTHRITIS – INSIGHT FROM THE ‘JAK-POT’ COLLABORATION
,
O. Zimmermann, E. Laügt, D. Mongin, R. Aymon, D. Choquette, L. Coupal, C. Codreanu, F. Iannone, R. F. Caporali, T. K. Kvien, S. Aarrestad Provan, B. F. Leeb, R. Fritsch-Stork, G. Lukina, D. Nordström, N. Trokovic, K. Pavelka, J. Závada, E. Vieira-Sousa, Z. Rotar, P. Sidiropoulos, A. Bertsias, A. Finckh, D. S. Courvoisier, K. Lauper
2026 POS1329
SEX DIFFERENCES IN b/tsDMARDs SAFETY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE JAK-pot INTERNATIONAL COLLABORATION
,
L. Otero Varela, B. Meuleman, D. Mongin, B. Gilbert, R. Guemara, L. Coupal, D. Choquette, C. Codreanu, R. Fritsch-Stork, R. F. Caporali, D. Huschek, K. Hyrich, F. Iannone, T. K. Kvien, D. Nordström, K. Pavelka, M. Pombo-Suarez, S. Aarrestad Provan, Z. Rotar, A. Strangfeld, N. Trokovic, J. Závada, S. S. Zhao, D. S. Courvoisier, A. Finckh, C. Sánchez-Piedra, K. Lauper
2026 POS1337
DIFFICULT-TO-MANAGE AXIAL SPONDYLOARTHRITIS IN 18,083 PATIENTS FROM FIVE NORDIC REGISTRIES – AN ANALYSIS INSPIRED BY RECENT ASAS DEFINITIONS
,
D. Di Giuseppe, L. M. Nielung, M. Lund Hetland, J. Askling, D. Nordström, S. Aarrestad Provan, B. Gudbjornsson, Ó. Pálsson, B. Delcoigne, L. W. Dreyer, B. Michelsen, M. de Vries, J. K. Wallman, B. Glintborg
[3]
Aas, E.
2026
2026 POS0036
COST-EFFECTIVENESS OF HERPES ZOSTER VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
,
G. Hagen, A. K. Opheim, J. Ovrebo, E. Aas, S. Aarrestad Provan
2026 POS0192
COST-EFFECTIVENESS OF A HIGH-INTENSITY EXERCISE PROGRAM FOR AXIAL SPONDYLOARTHRITIS: A MODELLING STUDY
,
F. Pavia, S. Aarrestad Provan, E. Aas, H. Solveig Dagfinrud, S. Sveaas, I. J. Berg, L. M. Sundbakk, G. Hagen
2026 POS0422
COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN IN 50-YEAR-OLD PATIENTS WITH RHEUMATOID ARTHRITIS IN NORWAY-A MARKOV MODELLING ANALYSIS
,
M. Alvino, S. Aarrestad Provan, E. Aas, G. Hagen
[9]
Abacar, K.
2026
2026 AB0513
LONG-TERM FOLLOW-UP OF PATIENTS WITH ANTI-MDA5 SYNDROME CONTEMPORANEOUS TO THE COVID-19 PANDEMIC (MIP-C) REVEALS A MILD PHENOTYPE IN SURVIVORS OF INITIAL COVID ERA PANDEMIC
,
F. Trunfio, A. Tonutti, K. Abacar, A. barr, P. David, G. de Marco, G. Tran, K. Iqbal, S. Wood, S. Nizam, M. Slade, Z. Ash, L. Coles, S. Savic, S. Maisuria, G. Arumugakani, C. Hettiarachchi, E. Payne, G. Smithson, R. Shah, J. Mclorinan, H. Reddy, S. Sultan, A. Altaie, D. Youssef, M. Keen, O. Sharif, M. Y. Md Yusof, F. del Galdo, A. Aslam, D. McGonagle
2026 AB1318
MUSCULOSKELETAL INVOLVEMENT IN TAKAYASU ARTERITIS ASSESSED BY PET/CT: AN AGE-RELATED TENDENCY TOWARDS A PMR-LIKE PATTERN
,
K. Abacar, Z. C. Balaban-Genç, A. Avcu, S. Özgüven, H. Direskeneli, F. Alibaz-Oner
2026 OP0276
THE EMERGENCE OF DISTINCT CD8
+
T CELL EFFECTOR PHENOTYPES IS ASSOCIATED WITH SUBCLINICAL SYNOVITIS WHEN RHEUMATOID ARTHRITIS IS IMMINENT
,
K. Abacar, F. Tariq, P. Martin, W. Ye, X. Sun, S. MacKay, D. Muldoon, L. Duquenne, A. Di Matteo, K. Harnden, K. Mbara, M. Menon, H. Al-Mossawi, M. Buch, P. Emery, D. Newton, B. Fairfax, K. Mankia
2026 OP0347
MRI TENOSYNOVITIS PREDICTS PROGRESSION TO INFLAMMATORY ARTHRITIS IN CCP-POSITIVE AT-RISK INDIVIDUALS BUT HAS LIMITED ADDITIONAL VALUE IN THOSE WHO ARE ULTRASOUND-NEGATIVE.
,
A. Di Matteo, K. Abacar, F. Salaffi, S. Farah, M. Carotti, D. Sahin, S. Sharrack, K. Harnden, H. J. Sugden, K. Smith, L. Duquenne, R. J. Wakefield, J. Nam, P. Emery, K. Mankia
2026 OP040
JAK-DEPENDENT REGULATION OF CXCL10, A KNOWN NOCICEPTIVE CHEMOKINE, IDENTIFIES A POTENTIAL TARGET UNDERLYING PAIN REDUCTION IN AN IN VITRO MODEL OF ENTHESITIS
,
F. Trunfio, T. Macleod, A. Tonutti, M. Harland, C. Wong, K. Abacar, R. Dunsmuir, N. Adsul, A. S. Rao, V. Borse, T. McMillan, M. Vomero, P. Loughenbury, L. Navarini, R. Giacomelli, A. Altaie, D. McGonagle
2026 POS0084
AXIAL–PERIPHERAL IMMUNE DIVERGENCE AT HUMAN ENTHESEAL SITES REVEALED BY SINGLE-CELL TRANSCRIPTOMICS
,
T. Macleod, M. Harland, C. Wong, K. Abacar, Y. Hamid, A. S. Rao, A. Khan, P. Loughenbury, V. Borse, C. MacEachern, A. P. Van den Heuvel, W. Chen, A. Altaie, D. McGonagle
2026 POS1031
CLINICAL COURSE AND RADIOLOGICAL OUTCOMES OF PULMONARY ARTERY THROMBOSIS IN BEHÇET’S DISEASE: A COMPARATIVE STUDY WITH NON-BEHÇET PULMONARY THROMBOSIS
,
A. Shikhaliyeva, O. Demircioglu, H. M. Vatansever, K. Abacar, A. Aliyeva, D. Kocakaya, T. Ergun, H. Direskeneli, F. Alibaz-Oner
2026 POS1281
PREDICTING CUMULATIVE SYMPTOM BURDEN AND DISEASE ACTIVITY IN ANTI-CCP POSITIVE INDIVIDUALS AT RISK OF RHEUMATOID ARTHRITIS USING MACHINE LEARNING FRAMEWORKS
,
K. Abacar, A. Di Matteo, L. Duquenne, K. Harnden, S. Sharrack, H. J. Sugden, J. Nam, P. Emery, K. Mankia
2026 POS1283
HIGH SENSITIVITY FLOW CYTOMETRY INCRIMINATES MEMORY B-CELLS IN PATIENTS FAILING ALL LICENSED b/tsDMARD CLASSES IN POLY-REFRACTORY RHEUMATOID ARTHRITIS: IMPLICATIONS FOR THERAPY SELECTION
,
A. Tonutti, K. Abacar, P. David, F. Trunfio, J. Nam, R. J. Wakefield, A. Di Matteo, K. Mankia, E. M. Vital, M. Y. Md Yusof, P. Emery, B. Saleem, S. Dass, A. Rawstron, D. McGonagle
Goto page:
10
50
100